UVA researchers found that continuous glucose monitor data can predict nerve, eye, and kidney damage from type 1 diabetes.

Discover how precision medicine and FDA's Project Optimus are transforming clinical trials in oncology drug development.

Enhance compliance and quality in the health and wellness market with Eurofins' GMP certification programme for dietary and ...

Grifols has received a $21 million grant from The Michael J. Fox Foundation to fund a pioneering study aimed at identifying ...

Discover the potential of macrocycles in drug discovery: flexible, cell-permeable molecules targeting undruggable proteins.

Discover key considerations for executing workflows in drug discovery, from defining research questions and generating ...

Researchers at UVA have developed computer models to create targeted antibiotics, aiming to combat antibiotic resistance.

LB Pharmaceuticals announced promising Phase II results for LB-102 in schizophrenia, demonstrating symptom improvement.

Discover Nuvia wPrime 2A Media, the advanced mixed-mode resin by Bio-Rad for efficient biomolecule purification at small to ...

Kindeva and Emervax partner to develop painless vaccine delivery technology, targeting viruses like Yellow Fever, Ebola, and ...

Explore the molecular changes in Rett syndrome. Find out how this breakthrough could lead to more effective treatments.